301370.SHE GKHT Medical Technology Co. Ltd. A
- Market cap
- CNY 3.86B
- P/E
- 410.5x
- P/B
- 1.51x
- ROE
- 0.6%
- Dividend yield
- 1.74%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301370.SHE undervalued?
Graham numberThe Graham number of GKHT Medical Technology Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GKHT Medical Technology Co. Ltd. A fundamental analysis
No fundamental analysis for GKHT Medical Technology Co. Ltd. A yet.
GKHT Medical Technology Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GKHT Medical Technology Co. Ltd. A
GKHT Medical Technology Co., Ltd. distributes and sells medical devices in China. The company offers vascular interventional therapy materials, orthopedic materials, neurosurgical materials, non-vascular interventional therapy materials, and dental materials. It also provides logistics and distribution services, as well as information products and services for medical devices. In addition, it provides professional services, including warehousing and logistics; distribution c…
Full company profileGKHT Medical Technology Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
GKHT Medical Technology Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 5.85B | 6.36B | 7.48B | 7.35B | 6.99B | 6.43B |
| Gross Profit | 827M | 840M | 879M | 791M | 742M | 604M |
| Operating Income | 419M | 370M | 338M | 252M | 213M | 104M |
| EBITDA | - | 636M | 427M | 362M | 224M | 53.8M |
| Net Income | 151M | 125M | 154M | 131M | 68.2M | 14.5M |
| EPS | 0.38 | 0.31 | 0.33 | 0.28 | 0.14 | 0.03 |
| Balance Sheet | ||||||
| Total Assets | 6.74B | 7.31B | 7.04B | 6.64B | 6.34B | 6.22B |
| Total Liabilities | 5.28B | 5.75B | 4.49B | 4.07B | 3.79B | 3.76B |
| Shareholders' Equity | 1.33B | 1.45B | 2.45B | 2.48B | 2.51B | 2.46B |
| Cash & Short-term Investments | 354M | 625M | 508M | 695M | 731M | 573M |
| Cash Flow | ||||||
| Operating Cash Flow | 284M | 481M | 717M | 649M | 678M | - |
| Capital Expenditure | 139M | 267M | 155M | 42.8M | 32.3M | 191M |
| Free Cash Flow | 146M | 214M | 562M | 606M | 646M | 317M |
| Ratios | ||||||
| ROE | 11.3% | 8.6% | 6.3% | 5.3% | 2.7% | 0.6% |
| ROA | 2.2% | 1.7% | 2.2% | 2.0% | 1.1% | 0.2% |
| Net Profit Margin | 2.6% | 2.0% | 2.1% | 1.8% | 1.0% | 0.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
GKHT Medical Technology Co. Ltd. A dividends
- Dividend yield
- 1.74%
- Forward dividend
- 0.12 CNY
- Payout ratio
- 98.7%
- Ex-dividend date
- Jun 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 67.3M | 0.14 | 98.7% |
| 2024 | CNY 111M | 0.23 | 84.6% |
| 2023 | CNY 99.6M | 0.21 | 64.7% |
| 2022 | CNY 122M | 0.31 | 97.7% |
| 2021 | CNY 129M | 0.32 | 85.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns GKHT Medical Technology Co. Ltd. A
- Insiders 53.18%
- Institutions 15.49%
- Public & others 31.33%
- Shares outstanding 471M
- Free float 270M
GKHT Medical Technology Co. Ltd. A company profile
- Company name
- GKHT Medical Technology Co. Ltd. A
- Ticker
- 301370.SHE
- ISIN
- CNE1000064P4
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 873
- Fiscal year end
- December
- Address
- Room 501C, Building 6, Beijing, China, 100176
- Phone
- 86 10 6786 7668
- Website
- gkht.com
About GKHT Medical Technology Co. Ltd. A
GKHT Medical Technology Co., Ltd. distributes and sells medical devices in China. The company offers vascular interventional therapy materials, orthopedic materials, neurosurgical materials, non-vascular interventional therapy materials, and dental materials. It also provides logistics and distribution services, as well as information products and services for medical devices. In addition, it provides professional services, including warehousing and logistics; distribution channel management; distribution process information management; and hospital SPD operation management. The company was founded in 2013 and is based in Beijing, China.
GKHT Medical Technology Co. Ltd. A management
6- Ms. Wei XiaoGM & Director · born 1982
- Mr. Jinhong WuDeputy GM, CFO, Head of Accounting Department & Accounting Supervisor · born 1979
- Ms. Xiaobei WangDeputy GM, Board Secretary & Director · born 1978
- Mr. Haipeng FeiDeputy General Manager · born 1975
- Mr. Wei LuDeputy General Manager · born 1976
- Mr. Hua LuoDeputy General Manager · born 1974